Pharmaceutical compositions in solid dosage units comprising microcapsules or inclusion complexes of ethyl esters of ?-3 polyunsaturated acids or suitable salts of the same ?-3 polyunsaturated acids, a competitive inhibitor of HMG-CoA reductase (statin), and pharmacologically acceptable excipients.